According to the latest data released by kang CMH on August 22, the total size of China's drug terminal market (excluding medicinal materials) reached 149.09 billion yuan in 2016, an increase of 8.2% year on year. It is expected to fall to around 5.8 per cent in 2017. With the introduction of comprehensive reform measures such as health insurance control fee, price reduction of drug bidding, centralized purchasing negotiation and insurance price negotiation, the driving force of drug sales growth is restricted.
The drug market returns to reason
The impact of new health reform on medicine and health industry is becoming increasingly prominent. In the early stage of "strong base and increased investment", it benefited from the policy dividend, and the pharmaceutical industry gained more than 17 percent in five consecutive years, even reaching 20 percent in 2010. As health reform enters the stage of "cost control and efficiency", the medical industry has continued to fall into single digits since 2015.
According to the big data statistics of caihui financial statistics, the market size of the terminal drug increased from 483.5 billion yuan to 14.909 billion yuan in 2008 and 2016, with an average annual compound growth of 15.1%. Chinese pharmaceutical enterprise management association ming-de yu believes that the next phase of the policy theme is to improve the drug quality, lower drug prices and drug abuse, the pharmaceutical industry growth or stability. China's drug market is expected to reach 15.773 billion yuan in 2017, up 5.8 percent from 2016, and its growth rate is down from a year earlier.
Ming-de yu said that with the new medical reform policy further fall to the ground, technology innovation comprehensive strength strong penetration, commercial insurance, speed up cross-border fusion, will create a basic medical and health consumption dual market structure; The health industry will gradually shift from product to service, and the supply chain structure of specialized division of labor and systematic service will be formed gradually.
The city level hospital occupies half the mountain
, according to statistics, CMH from six terminal market share, in 2016, the city level accounted for 55.0% of the medical market, hospital market of county level hospital market accounted for 17.8%, urban grassroots medical market and rural grassroots medical market accounted for less than 6.0%, respectively, of retail pharmacies accounted 16.4%, online pharmacies only accounted for 0.3%.
Grade hospitals are still the largest drug terminal markets. Among them, the position of city grade hospital is unshakable. In 2016, the market size of urban grade hospitals reached 820.3 billion yuan, a year-on-year increase of 9.2%.
The new health reform aims to reconfigure medical resources and to divert patients from large hospitals to primary medical institutions through measures such as tiered diagnosis, but the effect is still not clear.
According to the national health and family planning commission, the number of hospital visits reached 1.06 billion in the first four months of 2017, up 3.0 percent from the previous year. Among them, the number of tertiary hospitals increased by 5.4%, well above the national level (1.0%). The number of clinics in primary medical institutions increased slowly or slightly, and the total number of clinics in towns and villages decreased by 2.7% year on year.
In 2016, the market medicine size of county level hospitals reached 265.5 billion yuan, up 7.5% year on year. Over the past ten years, the county level hospital rapid growth of the size of the market, thanks to new farming and raising the level of the expansion of coverage and financing needs of clinic, and branded drug structure changes resulting from sinking. At present, the new rural cooperative coverage rate has reached 95%, the expansion space is getting smaller and smaller, and the regional growth rate of county grade hospital market is slowing down. China health information is expected to grow 6.3 percent in 2017, with a market size of 282.2 billion yuan.
In the primary medical market, the national health and family planning commission (NHFPC) data shows that in the first four months of 2017, the number of patients in the primary medical and health care institutions reached 1.42 billion, a decrease of 0.7% year-on-year.
|
